Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients with ESLD

NARecruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 5, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions
End-Stage Liver DIsease
Interventions
BIOLOGICAL

umbilical cord-mesenchymal stem cells

Umbilical cord mesenchymal stem cells injected through peripheral veins

Trial Locations (1)

110840

RECRUITING

General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER